Recognizing First Progression in Gastric Cancers
Optimizing 2/3L Therapy for GE Adenocarcinoma: RAINBOW Paclitaxel/Ramucirumab, Margetuximab/Pembro, Recurrence Treatment Approach
By
UChicago Medicine
FEATURING
Daniel Catenacci
By
UChicago Medicine
FEATURING
Daniel Catenacci
Login to view comments.
Click here to Login